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Key points
 Capillary rarefaction is hypothesized to contribute to impaired exercise tolerance in cardio-
vascular disease, but it remains a poorly exploited therapeutic target for improving skeletal muscle
performance.
 Using an abdominal aortic coarctation rat model of compensatory cardiac hypertrophy, we
determine the efficacy of aerobic exercise for the prevention of, and mechanical overload for,
restoration of hindlimb muscle fatigue resistance and microvascular impairment in the early
stages of heart disease.
 Impaired muscle fatigue resistance was found after development of cardiac hypertrophy, but
this impairment was prevented by low-intensity aerobic exercise and recovered after mechanical
stretch due to muscle overload.
 Changes in muscle fatigue resistance were closely related to functional (i.e. perfused) micro-
vascular density, independent of arterial blood flow, emphasizing the critical importance of
optimal capillary diffusion for skeletal muscle function.
 Pro-angiogenic therapies are an important tool for improving skeletal muscle function in the
incipient stages of heart disease.
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Abstract Microvascular rarefaction may contribute to declining skeletal muscle performance in
cardiac and vascular diseases. It remains uncertain to what extent microvascular rarefaction occurs
in the earliest stages of these conditions, if impaired blood flow is an aggravating factor and
whether angiogenesis restores muscle performance. To investigate this, the effects of aerobic exercise
(voluntary wheel running) and functional muscle overload on the performance, femoral blood flow
(FBF) and microvascular perfusion of the extensor digitorum longus (EDL) were determined in
a chronic rat model of compensatory cardiac hypertrophy (CCH, induced by surgically imposed
abdominal aortic coarctation). CCH was associated with hypertension (P = 0.001 vs. Control)
and increased relative heart mass (P < 0.001). Immediately upon placing the aortic band (i.e.
before development of CCH), post-fatigue test FBF was reduced (P < 0.003), coinciding with
attenuated fatigue resistance (P = 0.039) indicating an acute arterial perfusion constraint on muscle
performance.While FBFwas normalized duringCCH in chronic groups (P> 0.05) fatigue resistance
remained reduced (P = 0.039) and was associated with reduced (P = 0.009) functional capillarity
after development of CCH without intervention, indicating a microvascular limitation to muscle
performance. Normalization of functional capillarity after aerobic exercise (P = 0.065) and over-
load (P = 0.329) in CCH coincided with restoration to control levels of muscle fatigue resistance
(P > 0.999), although overload-induced EDL hypertrophy (P = 0.027) and wheel-running velocity
and duration (both P < 0.05) were attenuated after aortic banding. These data show that reductions
in skeletal muscle performance during CCH can be countered by improving functional capillarity,
providing a therapeutic target to improve skeletal muscle function in chronic diseases.
(Received 16 January 2021; accepted after revision 4 June 2021; first published online 9 June 2021)
Corresponding author Prof. S. Egginton: School of Biomedical Sciences, Faculty of Biological Sciences, University of
Leeds, Leeds LS2 9JT, UK. Email: s.egginton@leeds.ac.uk
Introduction
Persistent exercise intolerance is a hallmark of chronic
heart failure (CHF), compromising quality of life and
contributing to a poor clinical prognosis. Skeletal muscle
performance is, however, poorly correlated with left
ventricular ejection fraction in CHF (Franciosa et al.
1981; Rogers, 2001), suggesting that peripheral factors
determine the severity of exercise intolerance (Pandey
et al. 2015). Further pathological changes in CHF
contributing to impaired exercise performance include
sarcopenia and a slow-to-fast change in muscle fibre type
composition (Drexler et al. 1992). In addition, there is
growing evidence for constraints imposed by structural
and functional changes in the microcirculation in the
muscle (Duscha et al. 1999; Richardson et al. 2003;
Tickle et al. 2020). Reduced skeletal muscle microvascular
density occurs in both experimentally induced (Kindig
et al. 1999; Nusz et al. 2003; Richardson et al. 2003; Bowen
et al. 2017) and clinical (Schaufelberger et al. 1995; Duscha
et al. 1999;Wadowski et al. 2018)CHF, and this rarefaction
imposes a limit on the transfer of oxygen and nutrients,
and removal of waste products, to and from respiring
muscle tissue. Indeed, there is strong evidence for a
key role of the perfused microcirculation in determining
performance of cardiac (Hauton et al. 2015) and skeletal
muscle (Tickle et al. 2020). The perfused, or functional,
microcirculation is expected to be equivalent to the total,
or anatomical, microcirculation in healthy tissue, whereby
every vessel is available for blood flow. Experimentally
induced arteriolar blockade to simulate the early stages of
functional rarefaction indicates that muscle performance
is strongly associated with the degree of perfused
vessels, regardless of total underlying capillarity (Tickle
et al. 2020). Skeletal muscle capillary rarefaction after
imposition of cardiac dysfunction indicates that systemic
effects may occur soon (<21 days) after development of
perturbed heart function (Nusz et al. 2003), potentially
due to enhanced endothelial apoptosis (Rossig et al. 2000)
or increased vasoconstriction leading to arteriolar closure
(Prewitt et al. 1982). Coupled to the deleterious effects
of rarefaction, a disturbed anatomical distribution of
capillaries may also compromise muscle function because
increased heterogeneity of capillary spacing can reduce
tissue oxygenation (Piiper & Scheid, 1991; Degens et al.
2006b). Furthermore, animalmodels of CHF demonstrate
reduced red blood cell velocity and flux (Richardson et al.
2003), in addition to an increased proportion of capillaries
with intermittent RBC flux at rest and during contra-
ctile activity (Kindig et al. 1999). The consequent increase
in transit time potentially explains the higher oxygen
extraction observed in CHF (Katz et al. 2000), but also
suggests that muscle oxygenation is impaired, leading to
suboptimal mitochondrial function (Behnke et al. 2007).
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Improving muscle and exercise performance in CHF may
therefore depend upon restoration of optimal topology
of the microcirculation. However, it remains unknown
whether capillary distribution and/or capillary perfusion
is changed during CHF, and whether these putative
changes affect skeletal muscle oxygenation, performance
and capacity for adaptive remodelling.
Capillary proliferation from pre-existing vessels
(angiogenesis) in skeletal muscle is an essential adaptation
to match tissue performance to changing functional
demands (Brodal et al. 1977; Zumstein et al. 1983)
that is triggered by both physical and metabolic stimuli
(Hudlicka, 1991). For example, the increased longitudinal
strain on the abluminal capillary surface (Egginton
et al. 2001) during functional overload of a muscle (via
extirpation of a muscle synergist, hereafter ‘overload’)
not only results in hypertrophy (Zhou et al. 1998; Deveci
& Egginton, 2002; Tickle et al. 2020) and enhanced
fatigue resistance (i.e. slower rate of active force decline)
(Frischknecht & Vrbova, 1991; Ballak et al. 2016; Tickle
et al. 2020), but also induces angiogenesis (Egginton et al.
1998, 2011; Williams et al. 2006; Ballak et al. 2016). The
significance of angiogenesis for function is illustrated by
the observation that even after experimentally induced
functional capillary rarefaction, overload-mediated
angiogenesis can recover capillarization and fatigue
resistance in otherwise healthy muscle (Tickle et al. 2020).
In addition to the pro-angiogenic effects of longitudinal
strain, capillary proliferation can be induced by enhanced
vascular shear stress via application of a hyperaemic
stimulus such as occurs during chronic electrical
stimulation of muscle (Hudlicka et al. 1977; Egginton &
Hudlicka, 1999) or vasodilator administration (Egginton
et al. 2016; Mandel et al. 2016). While the hyperaemic
stimulus undoubtedly contributes to expansion of the
microvascular bed (Waters et al. 2004; Olesen et al.
2010) with prolonged aerobic exercise training (Andersen
& Henriksson, 1977), exercise-induced angiogenesis
is also mediated by metabolic (e.g. hypoxia, glucose
metabolism) factors (Olfert et al. 2016). In clinical
(Gustafsson et al. 2001; Esposito et al. 2010, 2018)
and experimental (Ranjbar et al. 2017) CHF, enhanced
capillarity and angiogenic signalling (e.g. via vascular
endothelial growth factor, VEGF) are found after exercise
therapy, indicating that the capacity for remodelling is
still present despite established disease. Improvements in
peak oxygen consumption after exercise therapy in CHF
patients are also considered to be driven by improvements
in peripheral microvascular function (Haykowsky et al.
2012). In CHF patients without exercise therapy, contra-
dictory data on angiogenic marker expression have been
reported. For instance, elevated VEGF (Valgimigli et al.
2004) is hypothesized to drive repair of endothelial
damage rather than expanding microvascular density
per se (Chong et al. 2004). In another study, however,
reduced VEGF expression (Arakawa et al. 2003) was
indicative of regulatory dysfunction and the potential
of multiple factors (e.g. severity and specific type of
CHF) to affect capillary proliferation in muscle tissue.
Nevertheless, the beneficial effects of exercise-induced
angiogenesis for restoring muscle function suggest that
intrinsic remodelling capacity may be harnessed, but this
remains a poorly exploited therapeutic target.
The principal objective of this paper was therefore to
quantify the functional and structural effects of angiogenic
stimuli on skeletal muscle during compensatory cardiac
hypertrophy (CCH) induced by coarctation of the
abdominal aorta (Degens et al. 2006a), a model of
incipient cardiac dysfunction. We tested in this rat
model the following specific hypotheses: (1) CCH has a
deleterious effect on skeletal muscle microcirculation and
fatigue resistance; (2) exercise prevents the adverse effects
of CCH on skeletal muscle; (3) overload has a restorative
effect on impaired skeletal muscle capillarization and
fatigue resistance in rats with CCH. By quantifying the
effects of cardiac dysfunction on skeletal muscle function
and microcirculation, we provide further evidence that
the perfused microvascular bed is a therapeutic target for




All experimental work complied with the UK Animals
(Scientific Procedures) Act 1986, and local approval
(70/08674) was granted by the University of Leeds Animal
Welfare and Ethical Review Committee. All experiments
conformed to the principles and regulations described by
guidelines published in the Journal of Physiology (Grundy,
2015).
Aortic constriction and EDL overload
Experiments were designed to enable comparison of the
effects of aerobic exercise and/or functional overload
on muscle morphology, performance and blood flow
after establishment of CCH. In-house bred male Wistar
rats were used throughout. While heart disease is not
specific to either sex, male rats were used as an extensive
body of complementary data is available, and constraints
of time and funding precluded an expansion of the
study. Compensatory cardiac hypertrophy was induced
via abdominal aortic constriction using a titanium band
(‘banded’ groups). Groups of aortic banded animals were
allocated as follows: (i) banded control (Aob: 304 ± 6 g,
N = 7); (ii) unilateral overload of the EDL (Aob+OV:
376± 6 g,N= 7); (iii) voluntarywheel running (Aob+EX:
305 ± 12 g, N = 7); (iv) acute banded, in which the
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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immediate effects of banding were quantified (Acute-Aob:
245 ± 40 g, N = 6). Corresponding non-banded groups
were also used: (i) intact (Control: 257 ± 8 g; N = 7); (ii)
overload (OV: 343 ± 9 g, N = 7); (iii) wheel running (EX:
316 ± 41 g, N = 8). Only EX and Aob+EX had access to
a cage wheel, all other groups were sedentary. All groups
had ad libitum access to food and water and were housed
under a 12 h light/dark cycle.
Under isoflurane anaesthesia (induction 4%,
maintenance 2.5%) rats underwent surgery to constrict
the abdominal aorta immediately cranial to the renal
artery bifurcations using a titanium clip (post-mortem
measured clip diameter: 0.37± 0.07mmLigaclip; Ethicon
Endo-Surgery Inc., Cincinnati, OH, USA) (Cornelussen
et al. 1994; Levy et al. 1996; Degens et al. 2006a). Depth
of anaesthesia was regularly assessed by testing the pedal
withdrawal reflex. Aob and Aob+EX were otherwise
intact. Unilateral mechanical overload of the extensor
digitorum longus (EDL) (Zhou et al. 1998; Deveci &
Egginton, 2002; Tickle et al. 2020) was performed in
Aob+OV 4 weeks after clip placement. In this procedure,
extirpation of the tibialis anterior induces stretch and
functional overload of the EDL. Post-operative analgesia
(buprenorphine (Vetergesic, Ceva, Amersham, UK)
0.05 mg kg−1) and antibiotic (Enrofloxacin (Baytril,
Bayer, Reading, UK) 2.5 mg kg−1) were provided after
all surgical procedures. Muscle fatigue resistance and
hindlimb perfusion in Aob and Aob+EX was quantified
4 weeks after aortic constriction, and in Aob+OV after
an additional 2 weeks.
The overload model of muscle angiogenesis was
selected because the success, or lack thereof, depends
upon weight-bearing and voluntary activity; actions that
may be easily translated to the clinical setting. In contrast,
other effective angiogenic stimuli such as imposition
of a clean stretch or elevated shear stress (e.g. via
electrical stimulation or α1-blocker administration) were
considered less suitable in this context because they either
require unwieldy treatment (e.g. fixing muscle length
for long periods by limb immobilization (Goldspink
et al. 1995)), potentially incur pharmaceutical side-effects,
may drive angiogenesis without corresponding functional
benefit (Kissane et al. 2021), and/or may compound
CHF-derived hypotension via vascular dilatation.
Wheel running
EX and Aob+EX animals were housed in a cage
with ad libitum access to an instrumented running
wheel that enabled real-time monitoring of night-time
exercise performance (distance moved, exercise duration
and running speed) via bespoke LabVIEW software
(‘Rodent voluntary exercise analysis system’ developed
in conjunction with the University of Manchester, UK).
Access to the wheel was provided immediately after aortic
constriction surgery for Aob+EX. To ensure access to the
running wheel was the same for each animal and exclude
erroneous data due to disturbance, all cage wheels were
locked during weekly cage cleaning and welfare checks.
Muscle fatigue resistance and hindlimb perfusion
Protocols for measuring muscle fatigue resistance and
arterial blood flow are described in Tickle et al (2020).
In brief, anaesthesia was induced with isoflurane (4%
in 100% O2) and thereafter maintained by constant
alfaxalone (Jurox, Crawley, UK) infusion (30–35 mg kg
hr−1) delivered via a catheter in the external jugular
vein. Implanted carotid and tail artery catheters allowed
continuous measurement (blood pressure transducer:
AD Instruments, UK) of central and peripheral blood
pressure, and heart rate. Adequate depth of surgical
anaesthesia was regularly assessed by reference to heart
rate and blood pressure in addition to tests of the pedal
withdrawal reflex.
Bilateral EDL isometric twitch force at optimal length
was measured by linking each muscle to a lever arm
force transducer (305B-LR: Aurora Scientific, Aurora,
ON, Canada) and providing supramaximal electrical
stimulation via the popliteal nerve (Hudlicka et al.
1977). Unimpeded access to the EDL was facilitated by
extirpation of the overlying synergist tibialis anterior.
To determine EDL fatigue resistance, a 30 s period of
1 Hz twitches, to activate the metabolic machinery, was
followed by 10 Hz impulses (0.3 ms pulse width, supra-
maximal voltage) for 180 s (Egginton & Hudlicka, 1999;
Tickle et al. 2020). No evidence ofmuscle ischaemia (rapid
decline in twitch force, slowing of twitch time course) was
noted during experiments, indicating that the stimulation
protocol did not constrainmuscle blood flowvia increased
intra-muscular pressure. Fatigue resistance was quantified
as a ‘fatigue index’ (FI) that was calculated as muscle force
at the end of the test divided by peak muscle tension at the
beginning of the test. A mean of five consecutive twitches
was selected to represent end-stimulation and peak force
data.
The femoral artery blood flow (FBF) was measured
bilaterally throughout each experiment with perivascular
flow probes (0.7PSB; Transonic, Ithaca, NY, USA) at
the proximal aspect of the profunda femoris arterial
bifurcation (Tickle et al. 2020). The muscle mass-specific
increase in flow, i.e. hyperaemic increment above resting,
was calculated to account for potential differences in EDL
mass and transformed to femoral vascular conductance
using arterial pressure measured in the tail. While
measured continuously, for clarity we present blood flow
at rest and immediately post-stimulation (when peak
blood flow was typically evident).
Following the conclusion of each experiment, capillary
perfusion was visualized by an injection of fluorescein
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isothiocyanate (FITC) – labelled dextran solution
(50 mg kg−1, MW = 500,000; Sigma, Poole, UK) via
the carotid artery (Tickle et al. 2020). Before and after
injection, the EDL in both legs were stimulated at 4 Hz
for 30 s to induce functional hyperaemia and capillary
recruitment. EDL were left in situ for a minimum of
1 min after injection to maximize dye localization in
perfused capillaries (Snyder et al. 1985). While still under
general anaesthesia, animals were then killed by cervical
dislocation.
Histology
Immediately after animals were killed, the EDL muscles
were removed, blotted dry and weighed. The muscle
was then frozen on cork with OCT embedding medium
(Thermo Scientific, Loughborough, UK) using liquid
nitrogen-cooled isopentane and stored at −80°C.
Ten-micrometre cryostat sections were prepared and
labelled with biotinylated Griffonia simplicifolia lectin I
(5 μl ml−1 FL-1101 GSL I; Vector Labs, Peterborough,
UK) and streptavidin Alexa Fluor 350 conjugate. For fibre
typing, serial sections were blocked in 10% goat serum in
PBS for 60min (Vector Laboratories,USA) then incubated
for 120 min with monoclonal antibodies BAD-5 (1:600),
SC-71 (1:600), 6H1 (1:50) on one slide and BF-F3 (1:100)
on another in blocking solution for fibre types I, IIa, IIx
and IIb, respectively (Developmental Studies Hybridoma
Bank, USA). After three 5 min washes in PBS the sections
were incubated in the dark with secondary antibodies
Alexa Fluor IgG2b for type I (1:500), Alexa Fluor IgG1
for type IIa (1:500) and Alexa Fluor 555 IgM for types
IIb and IIx (1:500) (Thermofisher Scientific, USA) in
blocking solution. After three further 5 min washes the
slides were mounted with ProLong Diamond Antifade
mountant (Thermofisher Scientific, USA). Whole-muscle
cross-sectional images were acquired with a confocal
microscope (Leica TCS SP5) at ×20 magnification.
Subsequent image analysis with BTablet and Anatis
(BaLoH Software, Ooij, The Netherlands) enabled
determination of fibre type, fibre cross-sectional area
and whether capillaries were perfused (i.e. FITC labelled).
To account for the regional heterogeneity of capillary
distribution and fibre-type composition (Kissane et al.
2018) three regions of interest (475 × 475 μm2) of the
whole-muscle image were used to establish an unbiased
counting frame with which to quantify muscle fibre type
composition (numerical fibre type proportions and the
specific fibre cross-sectional area, FCSA), capillarization
(expressed as capillary to fibre ratio, C:F, or capillary
density, CD) and capillary domain area (CDA). CDA
quantifies the area surrounding a capillary defined by
equidistant boundaries from adjacent capillaries and
is an index of the area of tissue to which a capillary
may supply adequate oxygen to working muscle (Hoofd
et al. 1985; Al-Shammari et al. 2014). Heterogeneity of
capillary distribution is provided by LogRSD. Capillary
localization was completed as described in Tickle et al.
(2020). Sample sizes for histological parameters were
reduced in EX (N = 5) and OV (N = 5) due to tissue
damage.
Mathematical modelling of tissue PO2 distribution
was performed in representative (N = 1 in each group)
EDL histological sections using a custom MATLAB
program (‘Oxygen Transport Modeler’) (Al-Shammari
et al. 2019). Model input assumptions include capillary
radius, muscle oxygen demand,myoglobin concentration,
oxygen solubility and diffusivity; and since measurements
of these parameters were not possible in this study, values
were applied uniformly across groups (Tickle et al. 2020).
Therefore, while the absolute values produced by this
model should be interpreted with caution, the calculated
tissuePO2 serves as an indicative comparison of the effects
of functional capillary rarefaction between groups.
Statistical analyses
In all cases, differences in FI, blood flow and histological
parameters between groups were quantified using
ANOVA with Tukey’s post hoc tests. ANCOVA with
Sidak’s post hoc tests were used to test whether aortic
banding influenced heart mass after controlling for the
scaling effect of body mass (Solomon & Bengele, 1973).
Statistical testing was conducted in SPSS (v.25). Data
are presented throughout as means ± SD unless stated
otherwise and statistical tests were considered significant
where P < 0.05.
Results
Cardiovascular effects of aortic banding
Acute-Aob had an mean arterial (carotid) pressure that
did not significantly differ from any group, while tail
pressure was lower than all other groups (P < 0.002),
thereby producing a greater carotid:tail BP ratio (Table 1;
P < 0.001). Carotid pressure was higher after chronic
banding compared with all unbanded groups (Fig. 1; Con
vs. Aob: P = 0.001; EX vs. Aob+EX: P = 0.026; OV vs.
Aob+OV: P = 0.031). Tail blood pressure was higher in
EX (P = 0.039) and Aob+EX (P = 0.016) than Control
(Table 1). There were no significant differences in heart
rate between groups.
Relative heart mass was lower in Control and OV
animals than in exercised (Con: P= 0.028; OV: P= 0.046)
and banded animals (Con vs. Aob:P< 0.001; vs. Aob+EX:
P < 0.001; vs. Aob+OV: P = 0.001; OV vs. Aob, Aob+EX
& Aob+OV: P < 0.001); the cardiac enlargement in EX
(compared with Control: P = 0.028) was smaller than the
compensatory hypertrophy in Aob (P= 0.005) but similar
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 1. Cardiovascular response to aortic banding
Control EX OV Acute-Aob Aob Aob + EX Aob + OV
Body mass (g) 254 ± 44ab 316 ± 41c 343 ± 23cd 245 ± 40a 304 ± 17bc 305 ± 33bc 375 ± 17d
Heart mass (% Mb) 0.27 ± 0.04a 0.32 ± 0.04b 0.26 ± 0.04a - 0.38 ± 0.04c 0.35 ± 0.04bc 0.35 ± 0.04bc
MAP (carotid) (mmHg) 122 ± 3a 124 ± 13a 123 ± 8a 139 ± 12ab 157 ± 25b 148 ± 14b 147 ± 11b
MAP (tail) (mmHg) 92 ± 7ab 115 ± 11c 92± 13a 58 ± 16d 115 ± 21bc 119 ± 12c 96 ± 15abc
Carotid:tail MAP ratio 1.33 ± 0.13a 1.08 ± 0.11a 1.36 ± 0.22a 2.54 ± 0.73b 1.39 ± 0.22a 1.25 ± 0.14a 1.55 ± 0.23a
Heart rate (bpm) 394 ± 43a 383 ± 53a 347 ± 48a 356 ± 68a 359 ± 59a 400 ± 43a 397 ± 31a
Abbreviations: Mb, body mass; MAP, mean arterial pressure. Statistically significant differences between groups across each row are
denoted by letters; groups sharing the same letter were not different, those with no shared letters were statistically different (P <
0.05) as determined by ANOVA with Tukey’s post hoc tests.
to Aob + EX (P = 0.904) and Aob + OV (P > 0.939);
there was no difference between banded groups’ heart
mass (Aob vs. Aob+EX: P = 0.349; Aob vs. Aob+OV:
P = 0.632; Aob+EX vs. Aob+OV: P = 0.999).
Wheel running
The velocity (week (wk) 1: P = 0.024; wks 2, 3 & 4: P <
0.001) and duration (wk 1: P = 0.014; wk 2, 3 & 4: P <
0.001) of each exercise bout, and therefore total distance
travelled (wk 1: P = 0.001; wk 2, 3 & 4: P < 0.001),
were significantly lower in Aob+EX than in EX, while
motivation to exercise (number of bouts) was otherwise
undiminished after band application (wk 1: P= 0.128; wk
2:P= 0.419; wk 3:P= 0.750; wk 4:P= 0.733), indicating a
constraint on voluntary exercise stamina imposed byCCH
(Fig. 2, Table 1).
Muscle performance
The FI was impaired compared with Control immediately
after band application (Acute-Aob (P < 0.001)) and
remained impaired after 4 weeks (P = 0.039; Fig. 3,
Table 2). The FI was comparable to Control in Aob+EX
(P = 0.999) and Aob+OV (P = 0.999) and was
significantly higher than Aob (P = 0.039) While overload
improved FI in OV (P = 0.036), FI in EX was similar to
Control (P = 0.954).
Femoral artery perfusion
Resting femoral artery flow (ml.min−1) was significantly
lower in Acute-Aob compared with all other groups
(vs. Control: P = 0.003; vs. OV: P = 0.036; vs. all
others: P < 0.001), Fig. 4A). End-stimulation FBF was
Figure 1. Hypertension after chronic abdominal aortic stenosis
Chronic restriction of blood flow via the abdominal aorta caused an increased mean carotid artery pressure at
4 weeks (aortic banded (Aob): N = 7; P = 0.001; aortic banded with exercise intervention (Aob + EX): N = 7;
P = 0.018) and 6 weeks (aortic banded with muscle overload (Aob + OV): N = 7; P = 0.027). An intermediate
blood pressure between unbanded (Control (N = 7); EX (N = 8); OV (N = 7) and banded animals was evident during
the acute phase after band application (Acute-Aob; N = 6). Statistically significant differences between groups are
denoted by letters; groups sharing the same letter were not different, those sharing none were statistically different
(P < 0.05) as determined by ANOVA with Tukey’s post hoc tests.
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Figure 2. Impaired voluntary wheel-running exercise performance after abdominal aortic banding
While inclination to exercise was undiminished (A), bout duration (B), velocity (C) and total distance travelled
(D) were reduced in banded animals (Aob+EX: dashed line) compared with exercise controls (EX: continuous
line). Interpolation lines fitted through the mean at each timepoint for each group. Asterisks denote statistical
significance between EX (N = 8) and Aob+EX (N = 7) at each timepoint (P < 0.05).
Figure 3. Impaired muscle fatigue resistance accompanied compensatory cardiac hypertrophy but
recovered after intervention
Fatigue index (FI) was reduced immediately after band application and remained impaired for 4 weeks without
intervention (Aob: P = 0.039). Exercise (Aob+EX) and overload (Aob+OV) recovered fatigue resistance to control
levels (both P = 0.999) despite the chronic effects of aortic banding. Group sizes were the same as in Fig. 1.
Statistically significant differences between groups are denoted by letters; groups sharing the same letter were not
different, those sharing none were statistically different (P < 0.05) as determined by ANOVA with Tukey’s post hoc
tests.
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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lower in the Acute-Aob than EX (P = 0.022), Aob+EX
(P = 0.018) and Aob+OV (P = 0.037) groups, but not
significantly different from Control (P = 0.255), OV
(P= 0.081) andAob (P= 0.177) (Fig. 4B; Table 2). Hyper-
aemic scope was similar in all groups. The magnitude
of hyperaemic flow per gramme of EDL did not differ
significantly between groups, even when accounting for
femoral vascular conductance per gramme of muscle
tissue (FVC) (Table 2).
Muscle mass and histology
EDL mass as a proportion of body mass was increased in
OV compared with Control (P = 0.036), Aob (P = 0.023)
and Aob+EX (P = 0.038), but was similar to EX
(P = 0.544) and Aob+OV (P = 0.938) (Table 3).
The magnitude of muscle hypertrophy after overload
was, however, greater in OV compared with Aob+OV
(P = 0.027; Table 3).
Anatomical CD did not differ significantly between
Control and any aortic banded animals (Aob: P = 0.999;
Aob+EX: P = 0.938; Aob+OV: P = 0.465). OV had
an increased anatomical CD compared with Control
(P = 0.029), thereby indicating angiogenesis had
occurred that exceeded the degree of fibre hypertrophy.
Development of CCH precipitated a significant reduction
in perfused CD in Aob (P < 0.001), Aob+EX (P = 0.001)
and Aob+OV (P < 0.001) (compared with non-banded
controls). Perfused CD was not significantly different
between banded groups (Table 3).
While anatomical C:F was unchanged across groups
compared with Control, it was increased in Aob+OV
comparedwithAob (P= 0.028) andAob+EX (P= 0.002).
Compared with unbanded groups, perfused C:F was
reduced in Aob (P = 0.009). In contrast, perfused C:F
was recovered in Aob+EX (P = 0.065) and Aob+OV
(P = 0.329) and was not significantly different (P < 0.05)
from Control (Table 3).
Compared with Control, anatomical CDA was
increased in Aob (P = 0.009) while similar in Aob+EX
(P = 0.845) and Aob+OV (P = 0.999) (Table 3). In
contrast, a more pronounced effect was obvious in the
Figure 4. Resting (A) and
end-stimulation (B) mean femoral
artery blood flow
A pronounced reduction in femoral blood
flow occurred immediately after aortic
stenosis (Acute-Aob) but was restored in
chronically banded animals. Group sizes
were the same as in Fig. 1. Statistically
significant differences between groups are
denoted by letters; groups sharing the same
letter were not different, those sharing
none were statistically different (P < 0.05)
as determined by ANOVA with Tukey’s post
hoc tests.
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Table 3. Microcirculatory and muscle fibre morphometric characteristics
Control EX OV Aob Aob + EX Aob + OV
EDL mass (mg per g Mb) 0.56 ± 0.06a 0.61 ± 0.05ab 0.66 ± 0.07b 0.56 ± 0.06a 0.56 ± 0.06a 0.63 ± 0.05ab
Bilateral EDL mass
hypertrophy
- - 1.23 ± 0.11a - - 1.12 ± 0.04b
Anatomical capillary
density (mm2)
616 ± 51a 696 ± 123ab 824 ± 142b 606 ± 123a 670 ± 78ab 722 ± 124ab
Perfused capillary
density (mm2)
570 ± 94a 668 ± 116a 728 ± 165a 259 ± 24b 397 ± 95b 366 ± 111b
Anatomical capillary:
muscle fibre ratio
1.47 ± 0.30ab 1.41 ± 0.12ab 1.61 ± 0.23ab 1.39 ± 0.39a 1.25 ± 0.11a 1.84 ± 0.22b
Perfused capillary:
muscle fibre ratio
1.25 ± 0.29ab 1.36 ± 0.13a 1.42 ± 0.31a 0.63 ± 0.24c 0.76 ± 0.19bc 0.90 ± 0.51abc
Anatomical capillary
domain area (μm2)
1392 ± 119a 1526 ± 268ab 1339 ± 184ab 1888 ± 407b 1547 ± 191ab 1417 ± 201a
Perfused capillary
domain area (μm2)
1823 ± 368ab 1575 ± 287a 1507 ± 225a 4525 ± 586c 2499 ± 641ab 2668 ± 923b
Anatomical logRSD 0.111 ± 0.010a 0.103 ± 0.010a 0.101 ± 0.009a 0.104 ± 0.008a 0.099 ± 0.011a 0.096 ± 0.011a
Perfused logRSD 0.127 ± 0.016ab 0.105 ± 0.010a 0.109 ± 0.010ab 0.131 ± 0.012b 0.124 ± 0.012ab 0.116 ± 0.015ab
EDL fibre composition:
Type I (%)
3.9 ± 2.3a 2.2 ± 1.3a 3.5 ± 2.7a 4.4 ± 2.4a 4.8 ± 1.7a 4.1 ± 1.5a
EDL fibre composition:
Type IIa (%)
21.9 ± 5.2a 25.3 ± 3.9a 23.2 ± 6.9a 23.5 ± 5.4a 26.3 ± 3.3a 23.3 ± 3.6a
EDL fibre composition:
Type IIb/IIx (%)
74.2 ± 7.2a 72.5 ± 4.5a 73.2 ± 9.5a 72.1 ± 7.4a 68.9 ± 3.6a 72.9 ± 3.9a
Type I FCSA (μm2) 922 ± 217a 922 ± 322a 986 ± 182ab 1151 ± 176ab 969 ± 164a 1340 ± 189b
Type IIa FCSA (μm2) 939 ± 105a 1102 ± 212ab 1109 ± 133ab 1178 ± 226ab 1054 ± 158a 1379 ± 103b
Type IIb/x FCSA (μm2) 1754 ± 296a 2520 ± 520bc 2061 ± 187abc 2435 ± 308bc 2079 ± 446ab 2730 ± 447c
Abbreviations: EDL, extensor digitorum longus; logrSD, logarithmic standard deviation of the radius of the capillary domains, i.e.
heterogeneity of capillary distribution; FCSA, fibre cross-sectional area. Statistically significant differences between groups across
each row are denoted by letters; groups sharing the same letter were not different, those with no shared letters were statistically
different (P < 0.05) as determined by ANOVA with Tukey’s post hoc tests.
perfused CDA where a significant increase was found
in Aob compared with all other groups (P < 0.001).
Intervention in Aob+EX (P = 0.285) and Aob+OV
(P = 0.103) reduced this value to levels statistically
non-significant from Control (Fig. 5, Table 3).
Neither anatomical LogRSD nor perfused LogRSD were
significantly different from Control in any group, and
no differences were found amongst Aob, Aob+EX or
Aob+OV.
Fibre-type composition did not differ significantly from
Control with any intervention. Types I, IIa and IIb/IIx
FCSA were, however, larger in Aob+OV when compared
with Control (Type I: P = 0.013; Type IIa: P < 0.001;
Type IIb/IIx: P = 0.001) and Aob+EX (Type I: P = 0.035;
Type IIa: P= 0.013; Type IIb/IIx: P= 0.046), while IIb/IIx
fibres were larger than Control in EX (P = 0.020), Aob
(P = 0.024) and Aob+OV (P = 0.001) (Table 3). Over-
load did not change FCSA in OV relative to Control
and did not increase in Aob+OV relative to either OV
or Aob.
PO2 modelling
Increased development of potential hypoxic regions
within the muscle was observed in Aob, with a
pronounced effect at moderate and high-intensity tissue
oxygen demand (Fig. 6). Compared with Aob, mean tissue
PO2 was improved in Aob+EX and Aob+OV (Fig. 6B),
resulting in a qualitative PO2 distribution similar to that
of Control. Within control groups, there was a modest
enhancement of tissue PO2 in EX and OV compared with
Con (Fig. 6A).
Discussion
In this paper we have demonstrated that CCH coincides
with rarefaction of functional capillaries and a reduction
in muscle fatigue resistance. Chronic mechanical stretch
via overload (analogous to resistance exercise) and
voluntary aerobic exercise recovered or prevented loss of
perfused capillaries in muscle tissue, thereby contributing
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to the maintenance of fatigue resistance. These data
indicate that the skeletal muscle microcirculation is a
major therapeutic target to restore muscle function in
patients with chronic diseases such as CHF.
Effects of acute aortic banding
There was a striking effect of banding and overload
or exercise on EDL fatigue resistance, highlighting the
sensitivity of skeletal muscle to both local and systemic
influences. Aortic banding precipitated an immediate
decline in muscle performance that remained reduced
in the long term. In the acute situation, reduced muscle
fatigue resistance may be due to an attenuated arterial
blood supply (corresponding to the low tail blood pressure
and reduced exercise-induced FBF), consistent with
impaired ischaemic muscle performance in conditions of
constrained feed artery perfusion (Fulgenzi et al. 1998;
Murthy et al. 2001).
Effects of chronic aortic banding
The left ventricular pressure overload induced by
abdominal aortic coarctation resulted, as expected, in
CCH as a consequence of chronic hypertension above
the stenosis (Cornelussen et al. 1994; Levy et al. 1996; De
Sousa et al. 2002; Degens et al. 2006a). Reversal of the
observed acute reduction in tail pressure was realized by
an increased hypertension indicating that homeostatic
mechanisms to maintain peripheral blood pressure were
effective during CCH. Yet, muscle fatigue resistance
was still reduced 4 weeks after banding despite a normal
exercise-induced increase in FBF.We infer that limitations
of muscle performance after long-term aortic banding
were due to changes within the muscle itself rather than
reduced arterial blood supply.
An earlier study using abdominal aortic
coarctation-induced CCH reported a muscle-specific
effect of CCH on FI, with functional impairments
occurring in the soleus and tibialis anterior, but not in the
EDL (Levy et al. 1996). Although we have no explanation
for the discrepancy between EDL performance in this
paper and Levy et al. (1996), it could be related to
methodological differences in the way in which fatigue
resistance was determined; 10 Hz stimulation used here
elicits a slower decline in force that likely accommodates
resolution of fine changes in force, which may be over-
looked during the rapid onset of fatigue during 40 Hz
stimulation (Levy et al. 1996).
We recently demonstrated that perfused capillary
density is a major determinant of fatigue resistance in
healthy skeletal muscle (Tickle et al. 2020), emphasizing
that microvascular impairment can contribute to
attenuated muscle performance. Capillary rarefaction
is associated with impaired exercise tolerance in clinical
(Gerovasili et al. 2009) heart disease (Duscha et al. 1999;
Nusz et al. 2003) and given the absence of changes in
arterial flow in our CCH rodent model, reduction in
the perfused muscle microcirculation was a potential
constraint on muscle function. Indeed, functional indices
of EDL capillarization were negatively affected after
development of CCH. Reduced functional (perfused) C:F
and CD in Aob also parallels the impaired skeletal muscle
blood flow reported in advanced CHF (Wilson et al.
1984; Sullivan et al. 1989; Musch & Terrell, 1992; Kindig
et al. 1999). Furthermore, we infer that a larger CDA
in Aob compromised fatigue resistance due to diffusion
limitations of oxygen (see Fig. 6). The pronounced decline
in modelled tissue PO2 in Aob indicates that rarefaction
of perfused vessels imposes a limitation on oxygen
diffusion that is exacerbated by exercise of increasing
intensity, leading to more rapid muscle fatigue than
seen in healthy tissue. That tissue PO2 is improved after
Figure 5. Deleterious enlargement of
capillary domain area is restored by
angiogenic intervention
Perfused capillary domain area (CDA) is
increased after banding (Aob: N = 7; P <
0.01) but treatment via exercise (Aob+EX:
N = 7) or overload (Aob+OV: N = 7)
recovers CDA back to control level (P >
0.05). Control (N = 7), EX (N = 5) and OV
(N = 5). Statistically significant differences
between groups are denoted by letters;
groups sharing the same letter were not
different, those sharing none were
statistically different (P < 0.05) as
determined by ANOVA with Tukey’s post
hoc tests.
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intervention following aortic constriction highlights the
potential efficacy of the functional microcirculation for
improving fatigue resistance. Interestingly, the PO2 model
outputs broadly correspond to experimental evidence
from exercising muscle tissue, whereby a large gradient
occurs between capillary and myoglobin-associated PO2
(Richardson et al. 1995; Poole et al. 2020).
Despite chronic groups undergoing at least 4 weeks
of abdominal aortic constriction, leading to functional
microvascular rarefaction, the total (anatomical) C:F
Figure 6. Simulation of muscle PO2 at rest, moderate and high rates of oxygen consumption
A, based on perfused capillary localization, areas of muscle hypoxia (deep blue shading, where PO2 < 0.5 mmHg)
increase after chronic application of an aortic band (Aob: D, J, P) and this pattern corresponds to functional capillary
rarefaction and impaired muscle fatigue resistance. Provision of exercise (Aob+EX: E, K, Q) or overload (Aob+OV:
F, L, R) improves muscle PO2 (warmer colours) and provides functional restoration of capillary domain area and
muscle fatigue resistance. There is consequently strong evidence for a directional change in PO2 although simulated
absolute PO2 values should be interpreted with caution due to the inherent limitations of modelling. B, average
tissue PO2 during resting (red), moderate (green) and high (blue) intensity tissue O2 demand. Data were calculated
using the exemplar images in (A), N = 1 in each group. [Colour figure can be viewed at wileyonlinelibrary.com]
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and CD were undiminished. This contrasts with other
reports of reduced anatomical CD in CHF (Nusz et al.
2003), hypertension (Serne et al. 2001) and hindlimb
ischaemia (Dai et al. 2002). While the determinant(s)
of this observed reduction in perfused capillaries cannot
be specified from the histological data presented in this
paper, it appears consistent with an initial (reversible)
phase of enhanced vasoconstriction-derived arteriolar
closure that, given more time, is followed by structural
capillary rarefaction because prolonged hypertension
leads to capillary apoptosis (Prewitt et al. 1982); therefore
our data are likely representative of the incipient phase of
microvascular deficit.
Adverse changes in functional capillarity and fatigue
resistance in Aob manifested during otherwise normal
FBF. Maintenance of femoral flow despite chronic hyper-
tension has been reported in other studies of abdominally
coarcted rats with impaired peripheral circulatory
structure or function (Overbeck, 1980; Boegehold
et al. 1991; Levy et al. 1996). For example, Boegehold
et al. (1991) reported peripheral arteriolar rarefaction
in the hindlimb of rats subjected to abdominal aortic
constriction, despite normal femoral arterial pressure.
Similarly, peripheral vascular resistance and impaired
hindlimb vasodilation develop after surgically imposed
abdominal aortic stenosis, despite no increase in local
femoral blood pressure (Bell & Overbeck, 1979; Over-
beck, 1980; Ungvari et al. 2004). Together, these findings
suggest that the mechanism(s) determining functional
rarefaction is pressure-independent and therefore derived
from systemic factors related to the development of
cardiac dysfunction. The established anti-angiogenic
effects of reactive oxygen species (Ungvari et al. 2004)
and inflammatory cytokines (Agnoletti et al. 1999;
Sun et al. 2007), which are both increased during
development of cardiac dysfunction, may determine
the progression of microvascular rarefaction. This may be
further compounded by disuse, as observed in the shorter
distanced travelled by Aob+EX, since inactivity leads to
microvascular supply deficiency (Kissane et al. 2019).
Despite impairments in the functional micro-
circulation, LogRSD was maintained in Aob, suggesting
that, at least in this early phase of CCH and hypertension,
heterogeneity of functional and anatomical capillary
spacing is unaffected, preventing further declines in
oxygen transport and muscle performance (Degens et al.
2006b; Al-Shammari et al. 2014). Shifts from slow to
fast in skeletal muscle fibre type and muscle atrophy
may develop with CHF and also contribute to exercise
intolerance (Mancini et al. 1992; De Sousa et al. 2002;
Carvalho et al. 2003), but these changes did not occur in
banded groups. We can therefore exclude these factors
as underlying the reduced fatigue resistance in our
aortic-banded rats. Changes in fibre type composition are
reported to occur 12 weeks after imposition of ascending
aortic stenosis and fibre atrophy by 24 weeks (Carvalho
et al. 2003), so the relatively short 4- to 6-week duration of
these experiments may not have been sufficient to observe
development of such impairments.
Exercise-mediated preservation of fatigue resistance
after aortic banding
Exercise induced an unexpectedly high peripheral blood
pressure, contrary to an expected exercise-induced hypo-
tensive effect (Pescatello et al. 1991). Compared with
Control, there was also an adaptive cardiac enlargement
with exercise (EX) that did not significantly differ in
magnitude from the reactive hypertrophy in Aob+EX
and Aob+OV, indicating the potential contributions of
adaptive (Moreira-Goncalves et al. 2015) and pathological
(Grossman et al. 1975) stimuli to cardiac growth.
Wheel-running exercise did not significantly enhance
FI in EX animals, but maintained muscle performance
in Aob+EX despite development of CCH. This suggests
that the level of exercise completed by animals was not
sufficient to register an improvement in the exercise
tolerance of the EDL muscle in EX, but was of sufficient
intensity to offset the pathological effects of CCH on
skeletal muscle in Aob. While inclination to exercise was
undiminished in Aob+EX, the duration and intensity
of each running bout was lower than in EX, leading
to a lower overall distance travelled, mirroring pre-
vious work in banded rats (De Sousa et al. 2002). Inter-
estingly, mean running velocity was reduced relative to
EX in Aob+EX indicating that onset of volitional exercise
fatigue contributed to declining (expected) locomotor
muscle power output, despite no differences in maximal
isometric twitch tension, i.e. muscle force generation
was not impaired per se, but other factors compromised
functional output. Nevertheless, the lesser amount of
exercise was sufficient to restore EDL function to normal
levels, thereby highlighting the beneficial effect of limited
aerobic activity to reverse pathological changes that
occur in skeletal muscle with CCH. Abnormalities in
mitochondrial function and muscle metabolism are also
reversed following voluntary exercise in clinical CHF
(Adamopoulos et al. 1993; Stratton et al. 1994; Hambrecht
et al. 1995) and an aortic coarctation model (De Sousa
et al. 2002; Gomes et al. 2016), so together these data
indicate that aerobic exercise provides a potent restorative
effect on skeletal muscle structure and function in various
stages of disease.
Voluntary wheel-running did not confer obvious
benefit on structural or functional muscle micro-
vasculature in unbanded rats, and in line with this,
muscle FI in EX was not significantly different from
Control. It is recognized that the pro-angiogenic effects
of exercise may not be activated below a critical threshold
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(Prior et al. 2003), so it is perhaps not surprising that
low-intensity wheel-running did not stimulate significant
capillary proliferation in EX. In contrast, aerobic exercise
after banding (Aob+EX) preserved functional CDA and
perfused C:F, thereby maintaining tissue oxygenation
and normal muscle FI (Al-Shammari et al. 2014).
Therefore, low-intensity aerobic exercise may stimulate
the reopening of hypertension-derived vasoconstricted
arterioles to allow for utilization of the underlying
functional microcirculation. The vasodilatory effects of
an increased production of nitric oxide (Koller et al. 1994)
and prostaglandins (Murrant et al. 2014) during exercise
may determine this potential for increased capillary
availability. Interestingly, although logRSD wasmaintained,
perfusedCD remained belowunbanded levels inAob+EX
indicating that microvascular remodelling after exercise
may be targeted to restore capillarity to meet local
functional requirements. Establishment of local hypoxic
regions within muscle upon microvascular rarefaction
with CCH (Fig. 6) may also contribute to a potentiated
angiogenic response because hypoxic and exercise stimuli
occur simultaneously, activating multiple proliferation
pathways (Adair, 2005). Many of the reported benefits
of exercise therapy in CHF (Belardinelli et al. 1999) may
therefore be in part due to microvascular remodelling.
Recovery of fatigue resistance by overload after
aortic banding
OV enhanced FI, as found in previous experimental
studies (Frischknecht & Vrbova, 1991; Degens et al. 1993;
Tickle et al. 2020). This benefit extended to animals with
CCH, where an FI improvement of ca 32% was recorded
in Aob+OV compared with a 25% enhancement in OV.
In this case, therefore, a targeted mechanical stimulus
without (obvious) systemic reciprocal effects leads to a
rapid restoration of muscle performance. This parallels
the enhanced muscle performance in CHF patients after
resistance exercise therapy (Selig et al. 2004; Braith et al.
2005; Braith & Beck, 2008; Giuliano et al. 2017).
Improved functional capillarity with overload was
accompanied by enhanced fatigue resistance, as reported
previously (Degens et al. 1992; Zhou et al. 1998; Deveci
& Egginton, 2002; Egginton et al. 2011; Ballak et al.
2016; Tickle et al. 2020), and parallels the upregulation
of angiogenic growth factor expression and capillarity
observed after resistance exercise in healthy subjects
(Gavin et al. 2007; Ferguson et al. 2018; Holloway
et al. 2018) and CHF patients (Williams et al. 2007).
Alleviation of symptoms associated with heart disease
may be hampered by coincident pathologies such as
impaired peripheral blood flow, reducing the angiogenic
effects of hyperaemic stimuli for expansion of the micro-
circulation. Interestingly, angiogenesis following overload
may occur in conditions of experimentally reduced
blood flow (Egginton et al. 1998; Deveci & Egginton,
2002), highlighting the potential of flow-independent
mechanical stimuli to improve muscle capillarity and
fatigue resistance, even in advanced disease. Therefore,
angiogenesis may contribute to improved capillary
perfusion by increasing the anatomical supply of micro-
vessels fed by patent arterioles, or elevated angiogenic
growth factor levels may attenuate capillary apoptosis.
This may occur in the sedentary overload model despite
a relative lack of shear stress-derived nitric oxide and
prostaglandin upregulation, which may otherwise
contribute to a reopening of constricted arterioles with
aerobic exercise intervention. The successful application
of muscle overload to rats with CCH provides further
evidence to support therapeutic resistance exercise, which
has the benefit of imparting additional cardiovascular
strain for short bouts in contrast to the long durations
required with aerobic exercise (Duncker et al. 2014) while
providing an effective method for improving muscle
function (Giuliano et al. 2017).
While EDL hypertrophy occurred in OV and Aob+OV,
relative mass gain was lower after development of CCH
although there were no significant differences in maximal
twitch force or FCSA. Impaired muscle hypertrophy with
induced CCH is similar to that reported in a rat model
of metabolic syndrome, where limited overload-induced
muscle growth was attributed to dysfunctional mTOR
signalling, a central regulator of growth and proliferation
(Katta et al. 2010; Paturi et al. 2010). Raised levels
of inflammatory cytokines, particularly TNFα, suppress
mTOR activity in heart failure (Seiler et al. 2016) and may
in part explain reduced gain in muscle mass in Aob+OV
(Schiaffino et al. 2013).
Greater capillarization is associated with enhanced
skeletal muscle fibre hypertrophy after resistance
exercise training (Snijders et al. 2017; Moro et al.
2019), highlighting the critical importance of the
microcirculation to muscle growth. Reduced functional
capillarization with CCH may therefore contribute to the
blunted hypertrophic response. Given the potential for
regrowth of the functional microcirculation in Aob+OV,
a longer period of overload may accommodate a full
restoration of capillary parameters.
Conclusion
We have demonstrated that functional microvascular
rarefaction with CCH underlies the impaired skeletal
muscle fatigue resistance in CCH. Loss of functional
capillarization can, however, be prevented through aerobic
exercise and restored by functional overload-derived
angiogenic stimuli, contributing to the successful recovery
of muscle performance. Therefore, improved fatigue
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resistance in Aob+EX and Aob+OV as a consequence of
improved functional capillarity supports the hypothesis
that skeletal muscle performance in CHF is primarily
determined by peripheral factors, specifically the muscle
microcirculation. These interpretations bear a caveat: we
have determined the effects on skeletal muscle function
of incipient cardiac dysfunction rather than advanced
disease, when co-morbidities add complexity to the
mechanisms of muscle dysfunction. Nevertheless, the
key determining role of muscle microcirculation in the
development of exercise impairments during cardiac
dysfunction underscore how angiogenic restorative
growth should be a key therapeutic target.
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Poor skeletal muscle function is thought to contribute to exercise intolerance in diseases such as chronic
heart failure. Tiny blood vessels are normally intertwined with muscle fibres to deliver oxygen and nutrients.
However, these capillaries become less abundant with the onset of disease, potentially causing a limitation on
how well the muscle can function. In this paper, we tested whether incipient heart disease (surgically induced
by hypertension-linked compensatory cardiac enlargement) in a rat model results in loss of blood-perfused
capillaries and muscle function, and whether aerobic exercise or muscle stretch are effective therapeutic
treatments for this impairment. Critically, loss of functional capillaries occurred alongside the onset of disease,
and this coincided with the muscle being prone to rapid fatigue. Despite the development of incipient heart
disease, aerobic exercise and muscle stretch independently normalized these pathological changes, resulting in
muscle fatigue that was indistinguishable from control values. This functional improvement after intervention
corresponded to an enhanced supply of perfused capillaries, which improved the oxygen supply to exercising
muscle tissue. These results highlight the efficacy of targeting the muscle capillaries for restoration of muscle
performance, and underscore the importance of this therapeutic target for alleviating the symptoms of exercise
intolerance in clinical disease.
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